Richard I. Horowitz, MD, and the MSIDS Research Foundation published findings today in the Journal of Alzheimer's DiseaseReports demonstrating that dapsone combination therapy (DCT), a short-course ...

Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...

The ability to reliably detect blood-based biomarkers such as brain-derived pTau 217 (BD-pTau 217) and α-synuclein species ...

A blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, predicted a faster buildup of ...

In Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, accumulation of aggregates of abnormally phosphorylated α-synuclein is observed, and these diseases are collectively ...

A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...

Researchers have discovered that a protein called phosphorylated -synuclein, which is associated with several neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, is also ...

Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to detect the earliest ...

Researchers have discovered that a protein called phosphorylated α-synuclein, which is associated with several neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, is also ...

Phosphorylated tau isn’t just pathological junk; it helps the brain defend against viral infections. So claim scientists led by Rudolph Tanzi and William Eimer at Massachusetts General Hospital in ...